Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Antithymocyte Globulins (ATG) as Part of the Myeloablative Conditioning (MAC) Regimen Can Reduce the Risk of Severe Graft-Vs.-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT) from Matched-Unrelated Donors (MUD).

Mohamad Mohty, MD, PhD, Marie- Lorraine Balere, Gerard Socie, Noel-Jean Milpied, PhD, Norbert Ifrah, MD, Mathieu Kuentz, MD, Jean-Luc Harousseau, Jean-Paul Vernant, Mauricette Michallet, MD, Agnes Buzyn, Jean-Yves Cahn, Jean-Henri Bourhis, Didier Blaise, MD, Colette Raffoux, Helene Esperou, Ibrahim Yakoub-Agha, MD, PhD

Blood (2008) 112 (11): 1151.

https://doi.org/10.1182/blood.V112.11.1151.1151

Published: 2008

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Louis Terriou, Zina Chir, Helene Esperou, Jean-Michel Boiron, Jean-Paul Vernant, Nicole Gratecos, Mauricette Michalet, Noel Milpied, Jean-Pierre Jouet, Ibrahim Yakoub-Agha, Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire

Blood (2007) 110 (11): 4924.

https://doi.org/10.1182/blood.V110.11.4924.4924

Published: 2007

Journal Articles

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

Blood (2007) 110 (7): 2749–2756.

https://doi.org/10.1182/blood-2007-03-079665

Published: 2007

Journal Articles

Breakthrough C. parapsilosis (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem Cell (HSC) Recipients Receiving Long Term Caspofungin (C) Therapy.

Nabil Kabbara, MD, Claire Lacroix, MD, Marie Robin, MD, Vanderson Rocha, MD, PHD, Regis Peffault de Latour, MD, Helene Esperou, MD, Agnes Devergie, MD, Eliane Gluckman, MD, PHD, Gerard Socie, MD, PHD, Patricia Ribaud, MD

Blood (2006) 108 (11): 5269.

https://doi.org/10.1182/blood.V108.11.5269.5269

Published: 2006

Journal Articles

I.V. Busulfan Given Based on Body Weight in Combination with Cyclophosphamide in Children: Pharmacokinetic and Clinical Results of a Myeloablative, Reduced-Toxicity Conditioning Regimen for Allogeneic Stem Cell Transplantation.

Helene Esperou, MD, Bénédicte Neven, MD, Karima Yakouben, MD, Claire Galambrun, MD, Françoise Méchinaud, MD, Catherine Paillard, MD, Pierre Bordigoni, MD, Hamadi Zouabi, MD, Laurent Nguyen, PharD, Gérard Michel, MD, Gilles Vassal, MD PhD

Blood (2006) 108 (11): 5131.

https://doi.org/10.1182/blood.V108.11.5131.5131

Published: 2006

Journal Articles

Alternative Donor Stem Cell Transplantation after Reduced Intensity Conditioning Regimen for Patients with Bone Marrow Failure.

Nabil Kabbara, MD, Vanderson Rocha, PhD, Marie Robin, MD, Agnes Devergie, MD, Patricia Ribaud, MD, Gerard Socie, PhD, Eliane Gluckman, MD, Helene Esperou, MD

Blood (2005) 106 (11): 2894.

https://doi.org/10.1182/blood.V106.11.2894.2894

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) with Reduced-Intensity Conditioning (RIC) in Children with Malignancies: A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).

Anne Sirvent, MD, Andre Baruchel, MD, Catherine Paillard, MD, Helene Esperou, MD, Pierre Bordigoni, MD, Jacques-Olivier Bay, MD, Gerard Michel, MD, Reza Tabrizi, MD, Jean-Pierre Vannier, MD, Claire Galambrun, MD, Agnes Buzyn, MD, Jean-Hugues Dalle, MD

Blood (2005) 106 (11): 3670.

https://doi.org/10.1182/blood.V106.11.3670.3670

Published: 2005

Journal Articles

Unexpected Fanconi Anemia Diagnosis in Patients with Bone Marrow Failure.

Fernando O. Pinto, MD, Thierry Leblanc, MD, Gwenaelle Le Roux, Helene Dastot, Moema Santos, MD, Jerome Larghero, PhD, Vanderson Rocha, MD, Helene Esperou, MD, Gerard Socie, MD, Andre Baruchel, MD, Eliane Gluckman, MD, Jean Soulier, MD, PhD

Blood (2005) 106 (11): 1056.

https://doi.org/10.1182/blood.V106.11.1056.1056

Published: 2005

Journal Articles

Is Antilymphocyte Globulin Useful in Conditioning Regimen of Unrelated Donor Hematopoïetic Stem Cell Transplantation?.

Helene Esperou, MD, Marie Lorraine Appert, MD, Ibrahim Yacoub Agha, MD, Noel Milpied, MD, Norbert Ifrah, MD, Mathieu Kuentz, MD, Zina Chir, Colette Raffoux, MD

Blood (2005) 106 (11): 2067.

https://doi.org/10.1182/blood.V106.11.2067.2067

Published: 2005

Journal Articles

Recipient Epstein Barr Virus (EBV) Seropositivity with IgG Antibodies Against Early Antigens (EA) Could Be a Predictive Marker for the Early Onset of Post Transplant Lymphoproliferative Disorders (PTLDs) after Allogeneic Non T Depleted Stem Cell Transplantation.

Felix Agbalika, MD, Jerome Larghero, MD-PhD, Dominique Marais, MD, Helene Esperou, MD, Gerard Socie, MD-PhD, Marc Benbunan, MD, Eliane Gluckman, MD-PhD, Jean Pierre Marolleau, MD

Blood (2004) 104 (11): 2263.

https://doi.org/10.1182/blood.V104.11.2263.2263

Published: 2004

Journal Articles

Genoidentical Donor Versus A, B, Cw, DR, DQ, HLA Allelic-Matched Unrelated Donor for Stem Cell Transplantation in Patients with Standard Risk Haematological Malignancy.

Ibrahim Yakoub-Agha, Jean-Michel Boiron, Mauricette Michallet, Noel Milpied, Jean-Henri Bourhis, Jean-Yves Cahn, Agnes Buzyn, Nicole Gratecos, Helene Esperou, Jean-Paul Vernant, Colette Raffoux, Jean-Louis Golmard, Jean-Pierre Jouet, Mathieu Kuentz

Blood (2004) 104 (11): 976.

https://doi.org/10.1182/blood.V104.11.976.976

Published: 2004

Journal Articles

Decreased Transplant Related Mortality and Better Survival in HLA Matched (12/12 A, B, C, DRB1, DQB1, DPB1) Unrelated Bone Marrow Transplants.

Alain Filion, MD, Pascale Loiseau, MD, Vanderson Rocha, MD, Ryad Tamouza, MD, Sylvie Chevret, Marc Busson, Helene Esperou, MD, Richard Traineau, MD, Gerard Socie, MD, Eliane Gluckman, MD, Dominique Charron, MD

Blood (2004) 104 (11): 977.

https://doi.org/10.1182/blood.V104.11.977.977

Published: 2004

Journal Articles

Final Height of Patients Who Underwent Bone Marrow Transplantation for Hematological Disorders During Childhood: A Study by the Working Party for Late Effects-EBMT

Amnon Cohen, Attilio Rovelli, Boudewijn Bakker, Cornelio Uderzo, Maria-Teresa van Lint, Helene Esperou, Alberto Gaiero, Alison D. Leiper, Roland Dopfer, Jean Yves Cahn, Franco Merlo, Hans J. Kolb, Gerard Socié

Blood (1999) 93 (12): 4109–4115.

https://doi.org/10.1182/blood.V93.12.4109

Published: 1999

NARROW

Antithymocyte Globulins (ATG) as Part of the Myeloablative Conditioning (MAC) Regimen Can Reduce the Risk of Severe Graft-Vs.-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT) from Matched-Unrelated Donors (MUD).

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

Breakthrough C. parapsilosis (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem Cell (HSC) Recipients Receiving Long Term Caspofungin (C) Therapy.

I.V. Busulfan Given Based on Body Weight in Combination with Cyclophosphamide in Children: Pharmacokinetic and Clinical Results of a Myeloablative, Reduced-Toxicity Conditioning Regimen for Allogeneic Stem Cell Transplantation.

Alternative Donor Stem Cell Transplantation after Reduced Intensity Conditioning Regimen for Patients with Bone Marrow Failure.

Allogeneic Stem Cell Transplantation (SCT) with Reduced-Intensity Conditioning (RIC) in Children with Malignancies: A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).

Unexpected Fanconi Anemia Diagnosis in Patients with Bone Marrow Failure.

Is Antilymphocyte Globulin Useful in Conditioning Regimen of Unrelated Donor Hematopoïetic Stem Cell Transplantation?.

Recipient Epstein Barr Virus (EBV) Seropositivity with IgG Antibodies Against Early Antigens (EA) Could Be a Predictive Marker for the Early Onset of Post Transplant Lymphoproliferative Disorders (PTLDs) after Allogeneic Non T Depleted Stem Cell Transplantation.

Genoidentical Donor Versus A, B, Cw, DR, DQ, HLA Allelic-Matched Unrelated Donor for Stem Cell Transplantation in Patients with Standard Risk Haematological Malignancy.

Decreased Transplant Related Mortality and Better Survival in HLA Matched (12/12 A, B, C, DRB1, DQB1, DPB1) Unrelated Bone Marrow Transplants.

Final Height of Patients Who Underwent Bone Marrow Transplantation for Hematological Disorders During Childhood: A Study by the Working Party for Late Effects-EBMT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only